Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas

AUTOR(ES)

Wang, Xing

FONTE

National Academy of Sciences

RESUMO

Thirty to forty percent of diffuse large B cell lymphomas (DLBCL) carry BCL-6 translocations that disrupt its 5′ regulatory region. This same region is also subject to somatic hypermutations, although only a small fraction of these mutations have a detectable effect on transcription. Here, we show that transcription of the BCL-6 gene is negatively self-regulated in multiple cell types. This mechanism operates by means of the interaction of two BCL-6-binding sites within exon 1 of the gene and the BCL-6 protein itself, which is a potent transcription repressor. Because the DLBCL-associated “activating mutations” specifically target these exon 1 binding sites, and because the entire exon 1 is usually removed in the BCL-6-translocated tumors, this autoregulation is bypassed in 30–40% of all DLBCL cases. Our results not only demonstrate an important mechanism governing the expression of BCL-6, but also explain how BCL-6 is deregulated in a large number of DLBCL patients, providing a better understanding of BCL-6-related lymphomagenesis.

Documentos Relacionados

• Analysis of CD10, BCL-6 and MUM1 im primary mediastinal large B cell lymphomas
• Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
• Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
• BCoR, a novel corepressor involved in BCL-6 repression
• BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci